Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-09-23 9:20 pm Sale | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 5,549,900 5.900% | -794,530 (-12.52%) | View |
2024-09-17 9:01 pm Sale | 13D | IO BIOTECH INC IOBT | Novo Holdings A/S | 5,823,584 8.500% | -1,075,000 (-15.58%) | View |
2024-06-24 9:06 pm Unchanged | 13D | GALECTO INC GLTO | Novo Holdings A/S | 2,497,791 9.200% | 0 (Unchanged) | View |
2024-05-14 9:35 pm Sale | 13G | IO BIOTECH INC IOBT | Novo Holdings A/S | 6,898,584 10.100% | -658,809 (-8.72%) | View |
2024-03-28 9:15 pm Sale | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 1,656,000 3.900% | -1,100,000 (-39.91%) | View |
2024-03-25 9:48 pm Sale | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 2,756,000 6.400% | -1,915,021 (-41.00%) | View |
2024-03-20 9:31 pm Sale | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 4,671,021 10.900% | -1,794,999 (-27.76%) | View |
2024-03-18 9:16 pm Sale | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 6,466,020 15.100% | -1,912,316 (-22.82%) | View |
2024-03-07 7:09 pm Sale | 13D | LAVA THERAPEUTICS N V SHS LVTX | Novo Holdings A/S | 0 0.000% | -1,878,194 (Position Closed) | View |
2024-02-14 4:55 pm Sale | 13G | Evotec SE EVO | Novo Holdings A/S | 14,931,858 8.400% | -2,512,949 (-14.41%) | View |
2024-02-13 9:34 pm Sale | 13D | IO BIOTECH INC IOBT | Novo Holdings A/S | 7,557,393 11.100% | -658,809 (-8.02%) | View |
2024-01-25 4:26 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 6,344,430 7.400% | 272,727 (+4.49%) | View |
2024-01-02 4:29 pm Sale | 13G | RALLYBIO CORP COM RLYB | Novo Holdings A/S | 1,767,861 4.700% | -528,146 (-23.00%) | View |
2023-12-15 4:55 pm Sale | 13D | ONKURE THERAPEUTICS, INC. CLAS OKUR | Novo Holdings A/S | 0 0.000% | -3,430,377 (Position Closed) | View |
2023-12-15 4:51 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Novo Holdings A/S | 1,307,829 4.900% | 13,776 (+1.06%) | View |
2023-11-24 4:33 pm Purchase | 13G | Lexeo Therapeutics Inc. LXEO | Novo Holdings A/S | 1,294,053 5.100% | 1,294,053 (New Position) | View |
2023-11-09 4:37 pm Sale | 13D | LAVA THERAPEUTICS N V SHS LVTX | Novo Holdings A/S | 1,878,194 7.100% | -521,806 (-21.74%) | View |
2023-08-11 4:40 pm Purchase | 13D | IO BIOTECH INC IOBT | Novo Holdings A/S | 8,216,202 12.000% | 4,938,270 (+150.65%) | View |
2023-08-03 5:02 pm Sale | 13D | Cyteir Therapeutics Inc. CYT | Novo Holdings A/S | 1,547,136 4.400% | -1,525,000 (-49.64%) | View |
2023-07-26 4:58 pm Sale | 13D | Cyteir Therapeutics Inc. CYT | Novo Holdings A/S | 3,072,136 8.700% | -868,277 (-22.04%) | View |